BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20150168)

  • 1. Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease.
    Ulrich C; Heine GH; Seibert E; Fliser D; Girndt M
    Nephrol Dial Transplant; 2010 Jul; 25(7):2265-72. PubMed ID: 20150168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of monocytic angiotensin-converting enzyme in dialysis patients with cardiovascular disease.
    Ulrich C; Heine GH; Garcia P; Reichart B; Georg T; Krause M; Köhler H; Girndt M
    Nephrol Dial Transplant; 2006 Jun; 21(6):1596-602. PubMed ID: 16476718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease.
    Rogacev KS; Seiler S; Zawada AM; Reichart B; Herath E; Roth D; Ulrich C; Fliser D; Heine GH
    Eur Heart J; 2011 Jan; 32(1):84-92. PubMed ID: 20943670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated CD14++CD16- monocytes predict cardiovascular events.
    Berg KE; Ljungcrantz I; Andersson L; Bryngelsson C; Hedblad B; Fredrikson GN; Nilsson J; Björkbacka H
    Circ Cardiovasc Genet; 2012 Feb; 5(1):122-31. PubMed ID: 22238190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography.
    Rogacev KS; Cremers B; Zawada AM; Seiler S; Binder N; Ege P; Große-Dunker G; Heisel I; Hornof F; Jeken J; Rebling NM; Ulrich C; Scheller B; Böhm M; Fliser D; Heine GH
    J Am Coll Cardiol; 2012 Oct; 60(16):1512-20. PubMed ID: 22999728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte subtypes predict clinical course and prognosis in human stroke.
    Urra X; Villamor N; Amaro S; Gómez-Choco M; Obach V; Oleaga L; Planas AM; Chamorro A
    J Cereb Blood Flow Metab; 2009 May; 29(5):994-1002. PubMed ID: 19293821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adding exercise to rosuvastatin treatment: influence on C-reactive protein, monocyte toll-like receptor 4 expression, and inflammatory monocyte (CD14+CD16+) population.
    Coen PM; Flynn MG; Markofski MM; Pence BD; Hannemann RE
    Metabolism; 2010 Dec; 59(12):1775-83. PubMed ID: 20580035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor expression on classic and pro-inflammatory blood monocytes after acute exercise in humans.
    Simpson RJ; McFarlin BK; McSporran C; Spielmann G; ó Hartaigh B; Guy K
    Brain Behav Immun; 2009 Feb; 23(2):232-9. PubMed ID: 18930806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte angiotensin converting enzyme expression may be associated with atherosclerosis rather than arteriosclerosis in hemodialysis patients.
    Ulrich C; Seibert E; Heine GH; Fliser D; Girndt M
    Clin J Am Soc Nephrol; 2011 Mar; 6(3):505-11. PubMed ID: 21127137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human monocyte heterogeneity--a nephrological perspective.
    Rogacev KS; Heine GH
    Nephrol Ther; 2010 Jul; 6(4):219-25. PubMed ID: 20447885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients.
    Ashman N; Macey MG; Fan SL; Azam U; Yaqoob MM
    Nephrol Dial Transplant; 2003 Oct; 18(10):2088-96. PubMed ID: 13679485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Losartan prevents the development of the pro-inflammatory monocytes CD14+CD16+ in haemodialysis patients.
    Merino A; Alvarez-Lara MA; Ramirez R; Carracedo J; Martin-Malo A; Aljama P
    Nephrol Dial Transplant; 2012 Jul; 27(7):2907-12. PubMed ID: 22247233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction.
    Tsujioka H; Imanishi T; Ikejima H; Kuroi A; Takarada S; Tanimoto T; Kitabata H; Okochi K; Arita Y; Ishibashi K; Komukai K; Kataiwa H; Nakamura N; Hirata K; Tanaka A; Akasaka T
    J Am Coll Cardiol; 2009 Jul; 54(2):130-8. PubMed ID: 19573729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of cardiac biomarkers for death in a non-dialysis chronic kidney disease population.
    Vickery S; Webb MC; Price CP; John RI; Abbas NA; Lamb EJ
    Nephrol Dial Transplant; 2008 Nov; 23(11):3546-53. PubMed ID: 18562472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial wave reflections and mortality in haemodialysis patients--only relevant in elderly, cardiovascularly compromised?
    Covic A; Mardare N; Gusbeth-Tatomir P; Prisada O; Sascau R; Goldsmith DJ
    Nephrol Dial Transplant; 2006 Oct; 21(10):2859-66. PubMed ID: 16854850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardized flow cytometry assay for identification of human monocytic heterogeneity and LRP1 expression in monocyte subpopulations: decreased expression of this receptor in nonclassical monocytes.
    Ferrer DG; Jaldín-Fincati JR; Amigone JL; Capra RH; Collino CJ; Albertini RA; Chiabrando GA
    Cytometry A; 2014 Jul; 85(7):601-10. PubMed ID: 24639232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion and differentiation of CD14+CD16(-) and CD14+ +CD16+ human monocyte subsets from cord blood CD34+ hematopoietic progenitors.
    Stec M; Weglarczyk K; Baran J; Zuba E; Mytar B; Pryjma J; Zembala M
    J Leukoc Biol; 2007 Sep; 82(3):594-602. PubMed ID: 17595380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated cardiac troponin T predicts cardiovascular events in asymptomatic continuous ambulatory peritoneal dialysis patients without a history of cardiovascular disease.
    Han SH; Choi HY; Kim DK; Moon SJ; Lee JE; Yoo TH; Kim BS; Kang SW; Choi KH; Lee HY; Han DS
    Am J Nephrol; 2009; 29(2):129-35. PubMed ID: 18719346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients.
    Liabeuf S; Barreto DV; Barreto FC; Chasseraud M; Brazier M; Choukroun G; Kamel S; Massy ZA
    Nephrol Dial Transplant; 2010 Aug; 25(8):2596-602. PubMed ID: 20190248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure.
    Wu CK; Luo JL; Tsai CT; Huang YT; Cheng CL; Lee JK; Lin LY; Lin JW; Hwang JJ; Chiang FT
    Pharmacogenomics J; 2010 Feb; 10(1):46-53. PubMed ID: 19752885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.